Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Deletion of HNF1A-AS1 Suppresses the Malignant Phenotypes of Breast Cancer Cells In Vitro and In Vivo Through Targeting miRNA-20a-5p/TRIM32 Axis
Qingjie Meng, Linlin Wang, Yonggang Lv, et al.
Cancer Biotherapy and Radiopharmaceuticals (2020) Vol. 36, Iss. 1, pp. 23-35
Closed Access | Times Cited: 17

Showing 17 citing articles:

lncRNAfunc: a knowledgebase of lncRNA function in human cancer
Mengyuan Yang, Huifen Lu, Jiajia Liu, et al.
Nucleic Acids Research (2021) Vol. 50, Iss. D1, pp. D1295-D1306
Open Access | Times Cited: 106
Oxidative Stress and Inflammation in Cardiovascular Diseases and Cancer: Role of Non-coding RNAs.
Pieterjan Ginckels, Paul Holvoet
PubMed (2022) Vol. 95, Iss. 1, pp. 129-152
Closed Access | Times Cited: 51
GCRFLDA: scoring lncRNA-disease associations using graph convolution matrix completion with conditional random field
Yongxian Fan, Meijun Chen, Xiaoyong Pan
Briefings in Bioinformatics (2021) Vol. 23, Iss. 1
Closed Access | Times Cited: 45
Circulating miRNAs in Breast Cancer Diagnosis and Prognosis
Bárbara Cardinali, Roberta Tasso, Patrizia Piccioli, et al.
Cancers (2022) Vol. 14, Iss. 9, pp. 2317-2317
Open Access | Times Cited: 33
Intricate confrontation: Research progress and application potential of TRIM family proteins in tumor immune escape
Junjie Gu, Jingyi Chen, Shuaixi Xiang, et al.
Journal of Advanced Research (2023) Vol. 54, pp. 147-179
Open Access | Times Cited: 12
Osthole exhibits an antitumor effect in retinoblastoma through inhibiting the PI3K/AKT/mTOR pathway via regulating the hsa_circ_0007534/miR-214-3p axis
Xiu-Fang Lv, Haojiang Yang, Hui Zhong, et al.
Pharmaceutical Biology (2022) Vol. 60, Iss. 1, pp. 417-426
Open Access | Times Cited: 15
The Role of SUMO E3 Ligases in Signaling Pathway of Cancer Cells
Xiaoxia Shi, Yixin Du, Shujing Li, et al.
International Journal of Molecular Sciences (2022) Vol. 23, Iss. 7, pp. 3639-3639
Open Access | Times Cited: 15
GATA1-Activated HNF1A-AS1 Facilitates the Progression of Triple-Negative Breast Cancer via Sponging miR-32-5p to Upregulate RNF38
Jingyu Yang, Heng Niu, Xin Chen
Cancer Management and Research (2021) Vol. Volume 13, pp. 1357-1369
Open Access | Times Cited: 17
HNF1A-AS1: A Tumor-associated Long Non-coding RNA
Yuling Liu, Fangnan Zhao, Fangshun Tan, et al.
Current Pharmaceutical Design (2022) Vol. 28, Iss. 21, pp. 1720-1729
Closed Access | Times Cited: 12
lncRNA FLVCR1‑AS1 drives colorectal cancer progression via modulation of the miR‑381/RAP2A axis
Yi Han, Xiaoyan Wang, Enqiang Mao, et al.
Molecular Medicine Reports (2020) Vol. 23, Iss. 2
Open Access | Times Cited: 17
MiR-20a-5p functions as a potent tumor suppressor by targeting PPP6C in acute myeloid leukemia
Fengchang Bao, Lei Zhang, Xiaohang Pei, et al.
PLoS ONE (2021) Vol. 16, Iss. 9, pp. e0256995-e0256995
Open Access | Times Cited: 12
sh-HNF1A-AS1 reduces the epithelial-mesenchymal transition and stemness of esophageal cancer cells
Zheng Wang, Yanfeng Huang, Ling Yu, et al.
Neoplasma (2022) Vol. 69, Iss. 03, pp. 560-570
Open Access | Times Cited: 7
Regulatory mechanisms and potential medical applications of HNF1A-AS1 in cancers.
Yang Zhang, Jiang Shi, Junfang Luo, et al.
PubMed (2022) Vol. 14, Iss. 6, pp. 4154-4168
Closed Access | Times Cited: 6
Inhibition of TRIM32 by ibr‐7 treatment sensitizes pancreatic cancer cells to gemcitabine via mTOR/p70S6K pathway
Bo Zhang, Youyou Yan, Yang‐qin Gu, et al.
Journal of Cellular and Molecular Medicine (2021) Vol. 26, Iss. 2, pp. 515-526
Open Access | Times Cited: 7
Hepatocyte nuclear factor 1A-antisense: Review of its role in the carcinogenesis
Soudeh Ghafouri‐Fard, Tayyebeh Khoshbakht, Mohammad Taheri, et al.
Pathology - Research and Practice (2021) Vol. 227, pp. 153623-153623
Closed Access | Times Cited: 5
Circular RNA circTMEM59 inhibits progression of pancreatic ductal adenocarcinoma by targeting miR-147b/SOCS1: An in vitro study
Tieliu Cao, Hong Liang, Dan Yu, et al.
Heliyon (2024) Vol. 10, Iss. 2, pp. e24402-e24402
Open Access
Current knowledge of antisense long non-coding RNA in the occurrence and prognosis of skull base tumors
Han Zhang, Qing-Wei Lv, Ziqiang Zheng, et al.
Heliyon (2024) Vol. 10, Iss. 16, pp. e35960-e35960
Open Access
Page 1

Scroll to top